Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct;91(10):1049-1055.
doi: 10.1007/s12098-023-04894-1. Epub 2023 Nov 15.

Juvenile Scleroderma

Affiliations
Review

Juvenile Scleroderma

Aruna Bhat. Indian J Pediatr. 2024 Oct.

Abstract

Localised scleroderma and systemic sclerosis are rare chronic fibrosing disorders seen in children, and are collectively referred to as Juvenile Scleroderma. Histopathology of the two forms is non-distinct but they differ in terms of vasculopathy, internal organ involvement, morbidity and mortality. Raynaud's phenomenon with digital tip ulcers is considered hallmark of systemic sclerosis. Quality of life gets greatly affected by these diseases. Early identification in the inflammatory phase of the disease, effective treatment and strict surveillance remain crucial for better outcomes. Emerging vascular and immunosuppressive strategies, coupled with efforts from scientific community to develop better biomarkers and monitoring tools, help constantly to improve survival rates.

Keywords: Digital ulcers; Juvenile scleroderma; Nail-fold capillaroscopy; Raynaud’s phenomenon; Systemic sclerosis.

PubMed Disclaimer

References

    1. Torok KS, Stevens AM. Juvenile systemic sclerosis. In: Petty R, Laxer R, Lindsley C, et al., editors. Textbook of Pediatric Rheumatology. 8th ed. Elsevier; Philadelphia; 2021. p. 377–401.
    1. Herrick A, Ennis H, Bhushan M, Silman AJ, Baildam EM. Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland. Arthritis Care Res (Hoboken). 2010;62:213–8. - DOI - PubMed
    1. Stevens AM, Kannan SB, Torok KS, et al. Brief report: HLA-DRB1, DQA1, and DQB1 in juvenile onset systemic sclerosis. Arthritis Rheumatol. 2016;68:2772–7. - DOI - PubMed - PMC
    1. Varga J, Trojanowska M, Kuwana M. Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities. J Scleroderma Related Disord. 2017;2:137–52. - DOI
    1. Mirizio E, Marathi A, Hershey N, et al. Identifying the signature immune phenotypes present in pediatric localized scleroderma. J Invest Dermatol. 2019;139:715–8. - DOI - PubMed

MeSH terms

Substances

Supplementary concepts

LinkOut - more resources